Consultants

MB ChB, FRCS(SN), MD

Ian Kamaly-Asl is a professor of paediatric neurosurgery based at Royal Manchester Children’s Hospital.  His neurosurgical training was in the North Western Deanery followed by fellowships at Harvard Medical School/Boston Children’s Hospital and The Hospital for Sick Children in Toronto.  He was appointed to his current post in 2005.

Ian is the neurosurgical lead for the paediatric neuro-oncology and paediatric neurovascular services and receives national and international patient referrals for these conditions.  Ian is the lead paediatric neurosurgeon for the neurofibromatosis type 1 and neurofibromatosis type 2 highly specialised services based at St Mary’s and for the proton radiotherapy national service based at The Christie Hospital.

For his leadership roles, Ian is a member of Council of the Society of British Neurological Surgeons where he is the national lead for bullying and undermining, he is the past chairman of the British Paediatric Neurosurgical Group, member of the Paediatric Neurosciences Clinical Reference Group and deputy clinical director of the North West Neurosciences Operational Delivery Network.

Ian has had various national roles in surgical education including member of the Neurosurgery Specialist Advisory Committee and National lead for simulation in neurosurgery.  He was previously secretary to the Neurosurgical National Selection Board and Training Programme Director of the North Western Deanery.

Ian has an active programme of clinical and basic science research.  He is the principal investigator for several national/international studies and has extensively published in peer reviewed journals, book chapters, national guidelines and presented over 100 papers at national/international meetings.  Ian is a member of the National Cancer Research Institute Children’s Group.